- Home
- CHRO vs INBS Comparison
CHRO vs INBS Comparison
Compare CHRO & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRO
- INBS
- Stock Information
- Founded
- CHRO 2002
- INBS 2016
- Country
- CHRO United States
- INBS United States
- Employees
- CHRO N/A
- INBS N/A
- Industry
- CHRO
- INBS Medical Specialities
- Sector
- CHRO
- INBS Health Care
- Exchange
- CHRO Nasdaq
- INBS Nasdaq
- Market Cap
- CHRO 8.1M
- INBS 8.6M
- IPO Year
- CHRO 2024
- INBS N/A
- Fundamental
- Price
- CHRO $1.37
- INBS $1.30
- Analyst Decision
- CHRO Strong Buy
- INBS
- Analyst Count
- CHRO 1
- INBS 0
- Target Price
- CHRO N/A
- INBS N/A
- AVG Volume (30 Days)
- CHRO 2.1M
- INBS 86.4K
- Earning Date
- CHRO 05-14-2025
- INBS 05-07-2025
- Dividend Yield
- CHRO N/A
- INBS N/A
- EPS Growth
- CHRO N/A
- INBS N/A
- EPS
- CHRO N/A
- INBS N/A
- Revenue
- CHRO N/A
- INBS $3,031,405.00
- Revenue This Year
- CHRO N/A
- INBS $280.88
- Revenue Next Year
- CHRO N/A
- INBS $126.26
- P/E Ratio
- CHRO N/A
- INBS N/A
- Revenue Growth
- CHRO N/A
- INBS 23.21
- 52 Week Low
- CHRO $0.45
- INBS $1.00
- 52 Week High
- CHRO $3.80
- INBS $3.04
- Technical
- Relative Strength Index (RSI)
- CHRO 46.67
- INBS 39.13
- Support Level
- CHRO $1.29
- INBS $1.34
- Resistance Level
- CHRO $1.65
- INBS $1.35
- Average True Range (ATR)
- CHRO 0.20
- INBS 0.12
- MACD
- CHRO 0.02
- INBS 0.02
- Stochastic Oscillator
- CHRO 13.81
- INBS 57.14
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).